Byju's, Pharmeasy among biggest underperformers in Prosus' India portfolio in H1
According to the firm’s half yearly financials, while Byju’s reported a negative internal rate of return (IRR) of 24 percent, Pharmaeasy gave Prosus 41 percent negative returns in H1 FY24.